PCI strategies in acute coronary syndromes without ST segment elevation (NSTEACS)

Georgios E. Christakopoulos, Subhash Banerjee, Emmanouil S. Brilakis

Research output: Chapter in Book/Report/Conference proceedingChapter


Coronary angiography and percutaneous coronary intervention (PCI) is a key for the effective management of patients presenting with non-ST segment elevation acute coronary syndromes (NSTEACS), as reflected in both the European Society of Cardiology (ESC) and the American Heart Association/American College of Cardiology. This chapter reviews risk stratification, patient selection for cardiac catheterization, the role of PCI for revascularizing these patients, and the recommended adjunctive pharmacologic therapy. Two risk scores that are commonly used currently for risk stratification of NSTEACS patients are the Global Registry of Acute Coronary Events (GRACE) score and the Thrombolysis in Myocardial Infarction (TIMI) score. Adjunctive pharmacologic therapy is critical for the success of PCI, but is also beneficial for patients treated with a conservative approach. Anticoagulation is recommended for all NSTEACS patients undergoing PCI to reduce the risk of intracoronary and catheter thrombus formation.

Original languageEnglish (US)
Title of host publicationInterventional Cardiology
Subtitle of host publicationPrinciples and Practice
Number of pages7
ISBN (Electronic)9781118983652
ISBN (Print)9781118976036
StatePublished - Nov 21 2016


  • Adjunctive pharmacologic therapy
  • American heart association
  • Coronary angiography
  • European society of cardiology
  • Global registry of acute coronary events
  • Non-st segment elevation acute coronary syndromes
  • Percutaneous coronary intervention
  • Thrombolysis in myocardial infarction

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'PCI strategies in acute coronary syndromes without ST segment elevation (NSTEACS)'. Together they form a unique fingerprint.

Cite this